Navigation Links
U of M researchers find cerebral malaria may be a major cause of brain injury in African children
Date:7/29/2008

Researchers at the University of Minnesota have found that cerebral malaria is related to long-term cognitive impairment in one of four child survivors. The research is published in the current issue of the journal Pediatrics.

Malaria is a leading cause of death for children in sub-Saharan Africa. Cerebral malaria, which affects more than 750,000 children a year, is one of the deadliest forms of malaria. It only takes one bite from an infected mosquito to contract the disease that directly affects the brain, causing fever, vomiting, chills, and coma.

"Children with cerebral malaria recover quite dramatically if they survive the period of coma," said Chandy John, M.D., associate professor of pediatrics at the University of Minnesota and principal investigator of the study. "But before this study, no one had prospectively assessed what happened to their thinking in the years after they had the cerebral malaria episode."

John worked with Michael Boivin, Ph.D., M.P.H., an expert in neuropsychology from Michigan State University, to evaluate cognitive function in children 5-12 years old with cerebral malaria who had been admitted to the Mulago Hospital, Kampala, Uganda. The children were evaluated for cognitive function in three major areas: attention, working memory, and tactile learning. Evaluation was done at hospitalization, six months after the initial malaria episode, and two years after the episode.

John and Boivin found that at six months, 21 percent of children with cerebral malaria had cognitive impairment compared with 6 percent of their healthy Ugandan peers. At two years, cognitive impairment was present in 26 percent of the patients, compared with 8 percent of the community children. These findings suggest that cognitive impairment may begin to manifest itself months after the initial episode. Cognitive function was most dramatically impaired in the area of attention. "The study has major public
'/>"/>

Contact: Kayla Kluver
kluve013@umn.edu
612-625-4119
University of Minnesota
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Researchers Map Americas Deadliest Roads
2. Researchers disprove long-standing belief about HIV treatment
3. Teamwork cuts out unnecessary biopsies, researchers find
4. Researchers probe geographical ties to ALS cases among 1991 Gulf War veterans
5. Montreal researchers prove that insulin-producing cells can give rise to stem-like cells in-vitro
6. Researchers Find Link Between Organ Transplants, Cancer
7. Tufts researchers discover link between DNA palindromes and disease
8. Researchers hone technique to KO pediatric brain tumors
9. Researchers link Huntingtons disease to overactive immune response in the brain
10. Researchers: Program discourages HIV transmission in Russia
11. Stanford Bio-X researchers use needle-thin probe to get first look at working muscle fiber

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... XenaCare Holdings has announced that it has b...on, one of the largest nonprofit organizations ded...cation. , Delray Beach, F...Inc. (OTCBB: XCHO), a company specializing in the ...thcare products, has announced today that is has b...
(Date:11/27/2009)... , SEATTLE, Nov. 27 Allrecipe...d-high Thanksgiving traffic numbers, with more tha..., providing a clear picture of what was served on ...Thanksgiving meal in 2009 weighed in at 2,225 calo...ear,s feast. According to the Allrecipes site, Sw...
(Date:11/27/2009)... Specialist manufacturers who use medical load...illions of dollars by bringing in technology partn... numbers of pro-active medical manufacturers are c... stage of their projects, ensuring that progress w...s or potentially outdated technology. , ...
(Date:11/26/2009)...ON, N.J., Nov. 27 The diabetes pop...er the next 25 years and annual medical spending o... from $113 billion today, according to a study pub...The National Changing Diabetes ® Program (NC...nalysis by a team from the University of Chicago. ...
(Date:11/26/2009)...g or too heavy can lead to strains or worse , ...e may be nothing wrong with stuffing your turkey f...same thing with your suitcase as you pack for holi...ed in 2008 in U.S. hospital emergency rooms, docto...for luggage-related injuries, such as muscle strai...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Pack Right for the Holidays to Avoid the ER 2
...event High Heel Hangover, SALEM, N.H., Dec. 3 Ev...ou feel after a day or night in heels. The dreaded...el hangover can be,eliminated from your life, with...t their bodies. Not only will your feet,ache, but ...
...euticals, Inc.,(Nasdaq: SGXP ) today announced th...ND) application to the U.S. Food and Drug Administ...developed, orally-bioavailable, small,molecule inh...008., "This IND submission is one quarter earlier...
... Partnerships with Centers of Influence, POWAY, C...), a leading provider of medical diagnostic imagin...pitals and imaging centers, today,announced the si...onths,ago of Digirad,s centers of influence busine...
...y 2008, TARRYTOWN, N.Y., Dec. 3 EpiCept Corporat...nnounced that it has,completed patient enrollment ... NP-1 cream. EpiCept NP-1 is a patented topical cr...europathies., (Logo: http://www.newscom.com/cgi-...
...illness and drug addiction so often go together" N...is may stem from a common cause: developmental cha...brain linked to fear, anxiety and other emotions. ...ociation (APA). , Dual diagnosis is common yet di...
...2 Forest,Laboratories, Inc. (NYSE: FRX ) and Myl...eived an approvable letter from the U.S. Food and ...rug Application (NDA) for,nebivolol (proposed bran...inspection of,a backup manufacturing facility in B...
Other Medicine News:Health News:High Heel Health 2Health News:SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor 2Health News:SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor 3Health News:Digirad Corporation and The Methodist Hospital in Houston Sign Letter of Agreement 2Health News:Digirad Corporation and The Methodist Hospital in Houston Sign Letter of Agreement 3Health News:Digirad Corporation and The Methodist Hospital in Houston Sign Letter of Agreement 4Health News:Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy 2Health News:Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy 3Health News:Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy 4Health News:Mental illness and drug addiction may co-occur due to disturbance in part of the brain 2Health News:Mental illness and drug addiction may co-occur due to disturbance in part of the brain 3Health News:FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension 2Health News:FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension 3
(Date:11/25/2009)...wswire/ -- ChemoCentryx, Inc., announced today t...PROTECT-1 (the Prospective Randomized Oral Therapy...EN(TM) (CCX282-B) in patients with moderate-to-sev... with a favorable safety and tolerability profile....cacy in the reduction of disease severity as defin...
(Date:11/24/2009)...- ,, WHAT: Rom Houbens, a Belgian man thought...to accident, was actually fully conscious and awak...orning America segment. The DynaVox EyeMax was fe...h Locked-in Syndrome and other conditions can unlo...a -- Tuesday, November 24 available online at ...
(Date:11/24/2009)...re-FirstCall/ -- Quest Diagnostics Incorporated (N...nostic testing, information and services, announce... Piper Jaffray Healthcare Conference in New York C... December 2, 2009 at 9:30 a.m. Eastern Time. ,,...its 2009 guidance for revenue growth to approximat...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX 0401 28Perifosine 29 at the 51st Annual Meeting of the A 6163 1Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX 0401 28Perifosine 29 at the 51st Annual Meeting of the A 6163 2Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX 0401 28Perifosine 29 at the 51st Annual Meeting of the A 6163 3Natural Alternatives International Inc Announces Filing of Patent Infringement Lawsuit 6158 1Natural Alternatives International Inc Announces Filing of Patent Infringement Lawsuit 6158 2When seconds count 3A Interventional radiology treatment for pulmonary embolism saves lives 61137 1When seconds count 3A Interventional radiology treatment for pulmonary embolism saves lives 61137 2When seconds count 3A Interventional radiology treatment for pulmonary embolism saves lives 61137 3
...idiary of,Pharmexa A/S, presents selected data fro...enza Conference entitled, "Options for,the Control...a. The,data show that a "universal" vaccine design...otect transgenic mice against,lethal experimental ...e 21, 2007-Pharmexa-Epimmune, the,U.S.-based subsi...
...WIRE)--Jun 21, 2007,- The Institute for OneWorld H...y, today announced that Phase 3 research,related t...Injection (Paromomycin), was published in the curr...NEJM). This clinical trial shows,that the medicine...o curing visceral leishmaniasis (VL), the world,s ...
Other Medicine Technology:Pharmexa A/S (DK) - Pharmexa presents data from influenza program 2Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 2Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 3Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 4
200 L Pipette Tip (RNase, DNase and pyrogen free)
MBP XLPFor Hard-to-Reach Places
MBP 300E Multi-Channel
Luteinizing hormone (LH) ELISA
Medicine Products: